Iora Health co-founder Rushika Fernandopulle, MD (Photo courtesy Iora Health)
Many startup companies in healthcare are entrepreneurial or innovative, but true disruptors in the field are harder to come by. These are the companies that are actually shaking the pillars of an established system. MedPage Today Editor-in-Chief Marty Makary, MD, MPH, of Johns Hopkins University in Baltimore, selected several companies that fit the profile of a real disruptor; we re profiling them in an ongoing series.
It s the Holy Grail of healthcare: improving quality while cutting costs. But how to do it?
Rushika Fernandopulle, MD, co-founder and CEO of Boston-based Iora Health, thinks he knows the answer double down on primary care.
email article
Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
FDA Drowned in Junk Science
Vanity Fair charts the trajectory of FDA Commissioner Stephen Hahn, MD, from being beaten down by President Trump to eventually standing up for science and all the odd requests he endured in between, staining the agency s once-sterling international reputation.
Hahn came to the helm of the FDA in mid-December 2019, just before the coronavirus pandemic broke out. Early in the pandemic, the agency was forced to entertain a tsunami of randoms when it came to pitches for COVID therapy which was made easier by a new White House email address created for the express purpose of routing VIP COVID pitches to the FDA and other agencies.